Literaturverzeichnis zum Titelthema “Neues aus der Dermatologie”
Bayerisches Ärzteblatt 6/2009, Seite 272 ff.
Professor Dr. Dr. h. c. Michael Landthaler
1. Eggermont AMM, Suciu S, Santinami M, Testori A, Kruit WHJ, Marsden J, Punt CJA, Salès F, Gore M, MacKie R, Kusic Z, Dummer R, Hauschild A, Musat E, Spatz A, Keilholz U
Adjuvant therapy with pegylated interferon α-2b versus observation alone in resected stage III melanoma: final results of EORTC 18991, a randomised phase III trial
Lancet 372: 117-126 (2008)
2. Garbe C, Terheyden P, Keilholz U, Kölbl O, Hauschild A Therapie des Melanoms
Dtsch Ärztebl 105 (49): 845-851 (2008)
3. Hafner C, van Oers JMM, Vogt T, Landthaler M, Stoehr R, Blaszyk H, Hofstaedter F, Zwarthoff EC, Hartmann A
Mosaicism of activating FGFR3 mutations in human skin causes epidermal nevi J Clin Invest 116: 2201-2207 (2006)
4. Hafner C, Hartmann A, Real FX, Hofstaedter F, Landthaler M, Vogt T
Sepctrum of FGFR3 mutations in multiple intraindividual seborrheic keratoses J Invest Dermatol 127: 1883-1885 (2007)
5. Hodi S, Friedlander P, Corless CL, Heinrich MC, MacRae S, Kruse A, Jagannathan J, Van den Abbeele AD, Velazquez EF, Demetri GD, Fisher DE
Major response to Imatinib mesylate in KIT-mutated melanoma J Clin Oncol 26: 2046-2051 (2008)
6. Kirkwood JM, Lee S, Moschos SJ, Albertini MR, Michalak JC, Sander C, Whiteside T, Butterfield LH, Weiner L
Immunogenicity and antitumor effects of vaccination with peptide vaccine +/- granulocyte- monocyte colony-stimulating factor and/or IFN-α2b in advanced metastatic melanoma: eastern cooperative oncology group phase II trial E1696
Clin Cancer Res 15: 1443-1451 (2009)
7. Leonardi CL, Kimball AB, Papp KA, Yeilding N, Guzzo C, Wang Y, Li S, Dooley LT, Gordon KB Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled trial
(PHOENIX 1)
Lancet 371: 1665-1674 (2008)
8. McDermott DF, Sosman JA, Gonzalez R, Hodi FS, Linette GP, Richards J, Jakub JW, Beeram M, Tarantolo S, Agarwala S, Frenette G, Puzanov I, Cranmer L, Lewis K, Kirkwood J, White JM, Xia C, Patel K, Hersh E
Double-blind randomised phase II study of the combination of sorafenib and dacarbazine in pa- tients with advanced melanoma: a report from the 11715 study group
J Clin Oncol 26: 2178-2185 (2008)
9. Morton DL, Thompson JF, Cochran AJ et al
Sentinel-node biopsy or nodal observation in melanoma N Engl J Med 355: 1307-1317 (2006)
10. Mrowietz U, Reich K
Psoriasis - neue Erkenntnisse zur Pathogenese und Therapie Dtsch Ärztebl 106: 11-19 (2009)
11. Nagel A, Hertl M, Eming R
Einsatz B-Zell-depletierender Antikörper bei Hauterkrankungen Hautarzt 59: 793-805 (2008)
12. Papp KA, Langley RG, Lewohl M, Krueger GG, Szapary P, Yeilding N, Guzzo C, Hsu MC, Wang Y, Li S, Dooley LT, Reich K
Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 52-week results from a randomised, double-blind, placebo-controlled trial
(PHOENIX2)
Lancet 371: 1675-1684 (2008)
13. Reichle A, Vogt T, Coras B, Terheyden P, Neuber K, Trefzer U, Schultz E, Berand A, Bröcker EB, Landthaler M, Andreesen R
Targeted combined anti-inflammatory and angiostatic therapy in advanced melanoma: a ran- domized phase II trial
Melanoma Research 17: 360-364 (2007)
14. Ruzicka T, Lynde CW, Jemec GBE, Diepgen T, Berth-Jones J, Coenraads PJ, Kaszuba A, Bis- sonnette R, Varjonen E, Holló P, Cambazard F, Lahfa M, Elsner P, Nyberg F, Svensson A, Brown TC, Harsch M, Maares J
Efficacy and safety of oral alitretinoin (9-cis retinoic acid) in patients with severe chronic hand eczema refractory to topical corticosteroids: results of a randomised, double-blind, placebo- controlled, multicentre trial
Br J Dermatol 158: 808-817 (2008) 15. Schulz ES, Schuler G
Impfstrategien zur Behandlung des Melanoms Hautarzt 59: 785-792 (2008)
16. Vogt T, Landthaler M, Reichle A, Rösch A
Die Melanomstammzelle: Kritische Würdigung eines radikal neues Konzepts J Onkol 4: 203-207 (2008)
17. Wheatley K, Ives N, Eggermont A, Kirkwood J, Cascinelli N, Markovic SN, Hancock B, Lee S Interferon-α as adjuvant therapy for melanoma: an individual patient data meta-analysis of ran- domised trials
J Clin Oncol 25: 8526 (2007)
